Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR

Biochemistry
Muthu RamakrishnanD Marsh

Abstract

Alpha-synuclein is a presynaptic protein, the A53T and A30P mutants of which are linked independently to early-onset familial Parkinson's disease. The association of wild-type alpha-synuclein with lipid membranes was characterized previously by electron spin resonance (ESR) spectroscopy with spin-labeled lipids [Ramakrishnan, M., Jensen, P. H., and Marsh, D. (2003) Biochemistry 42, 12919-12926]. Here, we study the interaction of the A53T and A30P alpha-synuclein mutants and a truncated form that lacks the acidic C-terminal domain with phosphatidylglycerol bilayer membranes, using anionic phospholipid spin labels. The strength of the interaction with phosphatidylglycerol membranes lies in the order: wild type approximately truncated > A53T > A30P > fibrils approximately 0, and only the truncated form interacts with phosphatidylcholine membranes. The selectivity of the interaction of the mutant alpha-synucleins with different spin-labeled lipid species is reduced considerably, relative to the wild-type protein, whereas that of the truncated protein is increased. Polarized infrared (IR) spectroscopy is used to study the interactions of the wild-type and truncated proteins with aligned lipid membranes and additionally to characteri...Continue Reading

References

Mar 14, 1968·Journal of Molecular Biology·A J GeddesE Beighton
May 23, 1998·The Journal of Biological Chemistry·W S DavidsonJ M George
Apr 5, 2001·Journal of Molecular Biology·D EliezerG Browne
Sep 25, 2003·The Journal of Biological Chemistry·Mihaela NeculaJeff Kuret
Jan 9, 2004·The Journal of Biological Chemistry·Evo LinderssonPoul H Jensen
Dec 14, 2004·The Journal of Biological Chemistry·Evo LinderssonPoul Henning Jensen

❮ Previous
Next ❯

Citations

Sep 15, 2010·Acta Neuropathologica·Ozlem Goker-AlpanEllen Sidransky
Jul 27, 2007·Cell Biochemistry and Biophysics·Klaus Beyer
Oct 8, 2011·Journal of the American Chemical Society·Nicholas P ReynoldsStefan Seeger
Mar 2, 2010·The Journal of Physical Chemistry. B·Farzin HaqueJennifer S Hovis
May 22, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Peizhou JiangShu-Hui Yen
May 11, 2011·Journal of Neuroinflammation·Lalida RojanathammaneeColin K Combs
Apr 5, 2011·Annual Review of Analytical Chemistry·Zachary D Schultz, Ira W Levin
Mar 9, 2011·Neurochemical Research·Susan A AustinColin K Combs
Aug 2, 2008·Methods : a Companion to Methods in Enzymology·Derek Marsh
Sep 30, 2008·Chembiochem : a European Journal of Chemical Biology·Malte DrescherMartina Huber
Aug 31, 2007·Proteins·Maja Mihajlovic, Themis Lazaridis
Oct 26, 2011·Biochimica Et Biophysica Acta·Leonid BreydoVladimir N Uversky
Feb 26, 2008·Biochimica Et Biophysica Acta·Derek Marsh
Jan 10, 2019·Cells·Helena XicoyGerard J M Martens
Sep 1, 2018·Light, Science & Applications·Dordaneh EtezadiHatice Altug
Jun 10, 2016·Science Translational Medicine·Roberto Di MaioJ Timothy Greenamyre
Dec 21, 2012·Nature Reviews. Neuroscience·Hilal A LashuelEliezer Masliah
Jun 14, 2019·Frontiers in Neurology·Andrew W Ferree
Dec 24, 2019·Frontiers in Molecular Neuroscience·Carroll Rutherford FieldsRichard Wade-Martins
Jun 3, 2008·Journal of the American Chemical Society·Malte DrescherMartina Huber
Oct 3, 2017·Journal of the American Chemical Society·Aditya IyerVinod Subramaniam
Sep 17, 2021·Biomaterials Science·Qingqing FanRona Chandrawati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.